CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Mast Therapeutics, Inc.  (MSTX)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Mast Therapeutics's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

MSTX Gross Margin (Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
Y / Y Revenue Change - - - - -
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 818 # 612 # # #
Seq. Revenue Change 84.44 % - - - -
Seq. Gross Profit Change - - - - -


Commenting Forth Quarter 2016 Gross Margin
Mast Therapeutics has managed to improve its Revenue sequentially to $0 millions by 84.44 % faster than Gross Profit increase of 84.44 % to $0 millions, this led to contraction in Gross Margin to 100 %, a new company low.

Observing forth quarter 2016 results within Major Pharmaceutical Preparations industry 68 other companies have achieved higher Gross Margin. While Gross Margin overall ranking has deteriorated compare to previous quarter from 612 to 818.
Learn about Gross Margin
MSTX's Gross Margin forth quarter 2016 Company Ranking
Within: No.
Industry # 69
Sector # 147
S&P 500 # 818

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Dec 31 2016)  

You need to upgrade your Flash Player


Financial Statements
Mast Therapeutics's (Dec 31 2016) Gross Profit $ 0 MSTX's Income Statement
Mast Therapeutics's (Dec 31 2015) Gross Profit $ 0 Quarterly MSTX's Growth
MSTX's Profits by Division See MSTX's Profits by Segment

Other Gross Margin Profitability Ratios
MSTX's Cumulative Gross Margin
Major Pharmaceutical Preparations Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
MSTX's Gross Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for MSTX's Competitors
Gross Margin Profit Margin for Mast Therapeutics's Suppliers
Gross Margin Profit Margin for MSTX's Customers

You may also want to know
MSTX's Annual Growth Rates MSTX's Profitability Ratios MSTX's Asset Turnover Ratio MSTX's Dividend Growth
MSTX's Roe MSTX's Valuation Ratios MSTX's Financial Strength Ratios MSTX's Gross Profit Growth
MSTX's Roa MSTX's Inventory Turnover Ratio MSTX's Growth Rates MSTX's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Dec 31 2016, within Major Pharmaceutical Preparations Industry Gross MarginDec 31 2016 MRQ Gross ProfitDec 31 2016 MRQ Revenue
Eagle Pharmaceuticals, Inc.  102.67 %$ 83.307 $ 81.140 
Kalvista Pharmaceuticals, Inc.  100.00 %$ 0.248 $ 0.248 
Karyopharm Therapeutics Inc.  100.00 %$ 0.047 $ 0.047 
Jazz Pharmaceuticals Plc  100.00 %$ 396.621 $ 396.621 
Seres Therapeutics, Inc.  100.00 %$ 3.037 $ 3.037 
Abeona Therapeutics Inc.  100.00 %$ 0.256 $ 0.256 
Ionis Pharmaceuticals Inc  100.00 %$ 160.349 $ 160.349 
Macrogenics Inc  100.00 %$ 5.106 $ 5.106 
Oncomed Pharmaceuticals Inc  100.00 %$ 6.219 $ 6.219 
Northwest Biotherapeutics Inc  100.00 %$ 0.071 $ 0.071 
Newlink Genetics Corp  100.00 %$ 12.703 $ 12.703 
Mast Therapeutics, Inc.  100.00 %$ 0.083 $ 0.083 
Ibio, Inc.  100.00 %$ 0.075 $ 0.075 
Genvec Inc  100.00 %$ 0.022 $ 0.022 
Epizyme, Inc.  100.00 %$ 0.478 $ 0.478 
Enanta Pharmaceuticals Inc  100.00 %$ 10.417 $ 10.417 
Endocyte Inc  100.00 %$ 0.013 $ 0.013 
Dynavax Technologies Corp  100.00 %$ 6.266 $ 6.266 
Evoke Pharma Inc  100.00 %$ 0.797 $ 0.797 
Eyegate Pharmaceuticals Inc  100.00 %$ 0.160 $ 0.160 
Geron Corp  100.00 %$ 0.094 $ 0.094 
Five Prime Therapeutics Inc  100.00 %$ 9.084 $ 9.084 
Fibrogen Inc  100.00 %$ 31.913 $ 31.913 
Fibrocell Science, Inc.  100.00 %$ 0.037 $ 0.037 
Onconova Therapeutics, Inc.  100.00 %$ 0.173 $ 0.173 
Ophthotech Corp.  100.00 %$ 5.322 $ 5.322 
Innoviva, Inc.  100.00 %$ 43.612 $ 43.612 
Titan Pharmaceuticals Inc  100.00 %$ 0.035 $ 0.035 
Stemline Therapeutics Inc  100.00 %$ 0.299 $ 0.299 
Steadymed Ltd.  100.00 %$ 0.320 $ 0.320 
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
RIZZEN's Profile
Stock Price
RIZZEN's Financials
RIZZEN's Expectations
Business Description
Fundamentals
Charts & Quotes
RIZZEN's News
Suppliers
RIZZEN's Competitors
Customers & Markets
Economic Indicators
RIZZEN's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com